OPV strains circulation in HIV infected infants after National Immunisation Days in Bangui, Central African Republic

BMC Research Notes

Volumn 3, Issue , 2010, Pages

  Manirakiza, Alexandre ^a   Picard, Emmanuella ^b   Ngbale, Richard ^b   Menard, Didier ^c   Gouandjika Vasilache, Ionela ^a  

^a INSTITUT PASTEUR DE BANGUI   (Central African Republic)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c INSTITUT PASTEUR DE MADAGASCAR   (Madagascar)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; POLIOVIRUS;

EID: 77953249384     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-3-136     Document Type: Article

References (22)

1. Duration of poliovirus excretion and its implications for accute flaccid paralysis surveillance: a review of the literature. JP Alexander Jr HE Gary Jr MA Pallansch, J Infect Dis 1997 175 176 S182 9203713
2. The biologic principles of poliovirus eradication. WR Dowdle ME Birmingham, J Infect Dise 1997 175 286 S292
3. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. OM Kew RW Sutter EM de Gourville WR Dowdle MA Pallansch, Annu Rev Microbiol 2005 59 587 635 10.1146/annurev.micro.58.030603.123625 16153180
4. Poliovirus vaccine strains detected in stool specimens of immunodeficient children in South Africa. DN Pavlov WB Van Zyl M Kruger L Blignaut WO Grabow MM Ehlers, Diagn Microbiol Infect Dis 2006 54 23 30 10.1016/j.diagmicrobio.2005. 08.011 16290028
5. Prevalence of vaccine-derived polioviruses in stools of immunodeficient children in South Africa. DN Pavlov WB Van Zyl J Van Heerden M Kruger L Blignaut WO Grabow MM Ehlers, J Appl Microbiol 2006 101 1367 1379 10.1111/j.1365-2672. 2006.03020.x 17105568 (Pubitemid 44715499)
6. HIV-infected children vaccination coverage and safety in a Western European cohort: a retrospective study. M Fernandez-Ibieta JT Ramos-Amador I Aunon-Martin, Int J STD AIDS 2007 18 351 353 10.1258/095646207780749763 17524201
7. HIV-infected children living in Central Africa have low persistence of antibodies to vaccines used in the Expanded Program on Immunization. MC Tejiokem I Gouandjika L Beniguel MC Zanga G Tene JC Gody E Njamkepo A Kfutwah I Penda C Bilong D Rousset R Pouillot F Tangy L Baril, PLoS One 2007 2 1260 10.1371/journal.pone.0001260 18060056
8. Atlas de la République Centrafricaine sur les Indicateurs du VIH et du SIDA in Enqute indicateurs multiples couplée avec la sérologie VIH et anémie en RCA, 2006. PNUD, 2008
9. No evidence of prolonged enterovirus excretion in HIV-seropositive patients. I Gouandjika-Vasilache C Akoua-Koffi E Begaud A Dosseh, Trop Med Int Health 2005 10 743 747 10.1111/j.1365-3156.2005.01454.x 16045460
10. Poliovirus vaccine shedding among persons with HIV in Abidjan, Cote d'Ivoire. KA Hennessey H Lago F Diomande C Akoua-Koffi VM Caceres MA Pallansch OM Kew M Nolan PL Zuber, J Infect Dis 2005 192 2124 2128 10.1086/498166 16288377
11. CD4 counts as surrogate makers for AIDS. JV Giorgi, Immunodeficientcy in HIV infection and AIDS S. Karger, Switzerland, Ianossy G, Autran B, Miedema F, 1992 13
12. Immunohematological reference ranges for adults from the Central African Republic. D Menard MJ Mandeng MB Tothy EK Kelembho G Gresenguet A Talarmin, Clin Diagn Lab Immunol 2003 10 443 445 12738646
13. Manual for virological investigation of poliomyelitis. WHO, Geneva, World Health Organisation 2004
14. L20B cells simplify culture of polioviruses from clinical samples. DJ Wood B Hull, J Med Virol 1999 58 188 192 10.1002/(SICI)1096-9071(199906)58: 2<188::AID-JMV15>3.0.CO;2-H 10335869
15. Natural genetic exchanges between vaccine and wild poliovirus strains in humans. S Guillot V Caro N Cuervo E Korotkova M Combiescu A Persu A Aubert-Combiescu F Delpeyroux R Crainic, J Virol 2000 74 8434 8443 10.1128/JVI.74.18.8434-8443.2000 10954543
16. The natural genomic variability of poliovirus analyzed by a restriction fragment length polymorphism assay. J Balanant S Guillot A Candrea F Delpeyroux R Crainic, Virol 1991 184 645 654 10.1016/0042-6822(91)90434-D
17. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. JD Thompson DG Higgins TJ Gibson, Nucleic Acids Res 1994 22 4673 4680 10.1093/nar/22.22.4673 7984417
18. Cell-mediated and humoral immune responses in children infected with human immunodeficiency virus during the first four years of life. W Borkowsky M Rigaud K Krasinski T Moore R Lawrence H Pollack, J Pediatr 1992 120 371 375 10.1016/S0022-3476(05)80899-6 1538282
19. Antibody response to diphtheria, tetanus, and poliomyelitis vaccines in relation to the number of CD4+ T lymphocytes in adults infected with human immunodeficiency virus. FP Kroon JT van Dissel J Labadie AM van Loon R van Furth, Clin Infect Dis 1995 21 1197 1203 8589143
20. Safety and immunogenicity of bacille Calmette-Guerin, diphtheria-tetanus-pertussis, and oral polio vaccines in newborn children in Zaire infected with human immunodeficiency virus type 1. RW Ryder MJ Oxtoby M Mvula V Batter E Baende W Nsa F Davachi S Hassig I Onorato A Deforest M Kashamuka WL Heyward, J Pediatr 1993 122 697 702 10.1016/S0022-3476(06)80007-7 8496745
21. Immunization of children at risk of infection with human immunodeficiency virus. WJ Moss CJ Clements NA Halsey, Bull World Health Organ 2003 81 61 70 12640478
22. Search for poliovirus carriers among people with primary immune deficiency diseases in the United States, Mexico, Brazil, and the United Kingdom. NA Halsey J Pinto F Espinosa-Rosales E da Silva AJ Khan AD Webster P Minor G Dunn E Asturias H Hussain MA Pallansch OM Kew J Winkelstein R Sutter, Bull World Health Organ 2004 82 3 8 15106294